Absci | Investor Presentation Deck | 37 slides

Absci · 2023-03
arc beats above · slides in the middle · loops below · scroll → 4 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

9
coverage by narrative range · generated from this deck JSON

Slide inventory

37
every slide · same image gating as the playbook
01
Slide 1
The slide uses code-like text as a design element to emphasize the company's computational approach to drug creation.front_matter
03
The slide uses a rhetorical question to challenge the status quo of the pharmaceutical industry.frame_problem
Open slide detailBeat · Why NowLoop · Why Now
04
Uses a process diagram to illustrate the inefficiency of traditional antibody discovery.frame_problem
Open slide detailBeat · Problem StatementLoop · Cost Of Inaction
05
Uses a visual comparison between small molecule data availability and biologic data scarcity.frame_problem
06
The slide uses a process flow to explain the technical solution.present_solution
Open slide detailBeat · Solution
07
The slide uses a code snippet at the top and a whiteboard diagram in the background to reinforce the technical nature of the 'creation' process.present_solution
08
The slide uses a flywheel-style diagram to represent the iterative nature of their drug discovery process.present_solution
09
The slide uses a spiral diagram to represent the iterative nature of their AI-driven drug discovery process.show_traction
Open slide detailBeat · Traction
10
Includes code snippet in top left and historical drug approval data in top right as context for the industry problem.inspire_vision
Open slide detailBeat · Thesis HeadlineLoop · Golden Circle
11
The slide uses a linear process flow to demonstrate the integration of AI across the drug development lifecycle.present_solution
12
The slide uses a process flow diagram to explain the 'zero-shot' capability of their AI platform.present_solution
Open slide detailBeat · Solution
13
The slide functions as a summary of a published scientific paper/case study.present_solution
14
The chart shows binding affinity (-log10(Kd)) vs sequence diversity (edit distance to trastuzumab) across search spaces ranging from millions to quadrillions.show_traction
Open slide detailBeat · TractionLoop · Before After
15
The chart is a dot plot showing naturalness score vs sequence diversity, with a red dashed line representing the wildtype baseline.show_traction
16
The slide uses a linear process flow to explain the Absci drug discovery platform.present_solution
Open slide detailBeat · Solution
17
Uses a Venn diagram to represent the intersection of three properties optimized by AI.present_solution
18
The slide uses a combination of scatter plots and marginal density plots to show data distribution and correlation metrics (Pearson/Spearman).show_traction
Open slide detailBeat · Traction
19
The chart shows a histogram of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.show_traction
20
The slide uses a linear process flow to explain the company's core technology platform.present_solution
21
The slide uses a stylized 'o' in 'potential' that matches the branding graphic on the left.transition
22
Includes a biological diagram of TLS and a Kaplan-Meier survival curve.analyze_data
23
The slide uses a linear process flow that loops back to show the end-to-end integration of biological and computational steps.present_solution
24
The pie chart labels are slightly ambiguous; the 26% slice is labeled 'Immuno-oncology', 39% 'Oncology', and 35% 'Autoimmunity and Inflammation'.show_traction
25
The slide uses a linear process flow to demonstrate the platform's capabilities.present_solution
26
The slide illustrates the mechanism of incorporating non-standard amino acids into antibodies for ADC development.present_solution
27
The slide uses a visual representation of bacterial cells to highlight three key engineering features: redox environment, expression control, and nsAA incorporapresent_solution
28
Case study showing molecular weight validation of protein expression.show_traction
29
The slide uses a four-column layout to categorize value propositions, each supported by a small icon or diagram.present_solution
30
PoS stands for Probability of Success. The slide uses a comparative timeline framework to illustrate efficiency gains.plan_implementation
31
The chart uses a dot-plot style to represent cash flow magnitude over time, color-coded by development stage.present_solution
32
The slide uses a split layout with imagery on the left and a KPI table on the right.show_traction
33
Uses testimonials/quotes from partners to establish credibility.show_traction
34
Includes a 'Chief Morale Officer' (a dog) as a lighthearted team member.other
35
The slide uses a grid layout to display headshots and credentials for both boards, followed by a row of corporate logos.cite_precedent
36
The slide uses a growth curve to illustrate technological progression over time.plan_implementation
37
transition